Sit Investment Associates Inc. Has $1.82 Million Holdings in Steris PLC (STE)
Sit Investment Associates Inc. cut its holdings in shares of Steris PLC (NYSE:STE) by 2.3% during the 4th quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The fund owned 17,040 shares of the medical equipment provider’s stock after selling 400 shares during the quarter. Sit Investment Associates Inc.’s holdings in Steris were worth $1,821,000 at the end of the most recent quarter.
A number of other hedge funds have also bought and sold shares of STE. Rehmann Capital Advisory Group raised its stake in shares of Steris by 15.6% in the 3rd quarter. Rehmann Capital Advisory Group now owns 712 shares of the medical equipment provider’s stock worth $81,000 after buying an additional 96 shares in the last quarter. State of Alaska Department of Revenue raised its position in shares of Steris by 2.0% during the fourth quarter. State of Alaska Department of Revenue now owns 8,892 shares of the medical equipment provider’s stock worth $950,000 after purchasing an additional 172 shares during the period. Steward Partners Investment Advisory LLC raised its position in shares of Steris by 118.0% during the third quarter. Steward Partners Investment Advisory LLC now owns 909 shares of the medical equipment provider’s stock worth $104,000 after purchasing an additional 492 shares during the period. DekaBank Deutsche Girozentrale raised its position in shares of Steris by 5.1% during the third quarter. DekaBank Deutsche Girozentrale now owns 12,929 shares of the medical equipment provider’s stock worth $1,477,000 after purchasing an additional 631 shares during the period. Finally, IFP Advisors Inc raised its position in shares of Steris by 46.6% during the third quarter. IFP Advisors Inc now owns 2,019 shares of the medical equipment provider’s stock worth $231,000 after purchasing an additional 642 shares during the period. Institutional investors own 87.07% of the company’s stock.
Shares of NYSE STE opened at $112.65 on Friday. The company has a current ratio of 2.63, a quick ratio of 2.01 and a debt-to-equity ratio of 0.41. Steris PLC has a one year low of $82.88 and a one year high of $121.67. The stock has a market capitalization of $9.40 billion, a price-to-earnings ratio of 27.14 and a beta of 1.08.
The company also recently announced a quarterly dividend, which was paid on Friday, December 21st. Shareholders of record on Wednesday, November 28th were paid a $0.34 dividend. The ex-dividend date of this dividend was Tuesday, November 27th. This represents a $1.36 dividend on an annualized basis and a yield of 1.21%. Steris’s dividend payout ratio (DPR) is currently 32.77%.
STE has been the topic of a number of research analyst reports. Sidoti lifted their price target on Steris from $155.00 to $157.00 and gave the company a “buy” rating in a report on Thursday, December 6th. KeyCorp lifted their price target on Steris from $120.00 to $132.00 and gave the company an “overweight” rating in a report on Tuesday, November 13th. Finally, Zacks Investment Research upgraded Steris from a “sell” rating to a “hold” rating in a report on Thursday, September 20th. Six investment analysts have rated the stock with a buy rating, Steris has a consensus rating of “Buy” and an average target price of $128.83.
In other Steris news, VP John Adam Zangerle sold 1,750 shares of the stock in a transaction on Friday, January 11th. The stock was sold at an average price of $110.00, for a total value of $192,500.00. Following the transaction, the vice president now directly owns 32,546 shares in the company, valued at approximately $3,580,060. The sale was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this link. Also, CEO Walter M. Rosebrough, Jr. sold 10,000 shares of the stock in a transaction on Wednesday, November 7th. The shares were sold at an average price of $120.50, for a total value of $1,205,000.00. The disclosure for this sale can be found here. Insiders sold 46,250 shares of company stock worth $5,508,520 in the last 90 days. Corporate insiders own 2.38% of the company’s stock.
TRADEMARK VIOLATION WARNING: “Sit Investment Associates Inc. Has $1.82 Million Holdings in Steris PLC (STE)” was originally published by Daily Political and is the sole property of of Daily Political. If you are accessing this piece on another publication, it was illegally stolen and reposted in violation of international copyright legislation. The original version of this piece can be accessed at https://www.dailypolitical.com/2019/01/18/sit-investment-associates-inc-has-1-82-million-holdings-in-steris-plc-ste.html.
STERIS plc provides infection prevention and other procedural products and services worldwide. The company operates in four segments: Healthcare Products, Healthcare Specialty Services, Life Sciences, and Applied Sterilization Technologies. The Healthcare Products segment offers cleaning chemistries and sterility assurance products; accessories for gastrointestinal (GI) procedures, washers, sterilizers, and other pieces of capital equipment for the operations of a sterile processing department; and equipment used in the operating room, including surgical tables, lights, equipment management services, and connectivity solutions.
Featured Story: Back-End Load
Want to see what other hedge funds are holding STE? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Steris PLC (NYSE:STE).
Receive News & Ratings for Steris Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Steris and related companies with MarketBeat.com's FREE daily email newsletter.